scholarly journals Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: A single center experience

2012 ◽  
Vol 28 (3) ◽  
pp. 835-840 ◽  
Author(s):  
HIROKI NISHIKAWA ◽  
MITSURU TSUDO ◽  
YUKIO OSAKI
2000 ◽  
Vol 79 (9) ◽  
pp. 530-532 ◽  
Author(s):  
I. Genvresse ◽  
E. Späth-Schwalbe ◽  
H. Meisel ◽  
O. Kaufmann ◽  
D. H. Krüger ◽  
...  

2005 ◽  
Vol 36 (8) ◽  
pp. 878-885 ◽  
Author(s):  
Morishige Takeshita ◽  
Hironori Sakai ◽  
Seiichi Okamura ◽  
Yumi Oshiro ◽  
Koichi Higaki ◽  
...  

Author(s):  
Alyssa Gallipani ◽  
Agnes Cha ◽  
Leonard Berkowitz ◽  
Anjali Bakshi

This report describes a case of concomitant treatment of advanced diffuse large B-cell lymphoma with chemoimmunotherapy along with direct-acting antivirals for hepatitis C virus in a patient coinfected with HIV. The patient tolerated gemcitabine, dexamethasone, cisplatin, and rituximab and achieved sustained virologic response after treatment with ledipasvir/sofosbuvir.


Oncotarget ◽  
2017 ◽  
Vol 8 (68) ◽  
pp. 112384-112389 ◽  
Author(s):  
De Zhou ◽  
Changqian Bao ◽  
Xiujin Ye ◽  
Lixia Zhu ◽  
Jingjing Zhu ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document